- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02040077
Evaluation of a Computerized Opioid Overdose Prevention Program
Development and Validation of a Computerized Opioid Overdose Intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- Johns Hopkins University Bayview Medical Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age (>18yrs old)
- Past yr diagnosis of opioid dependence
- Recent completion of opioid detoxification
Exclusion Criteria:
- Completion of local overdose prevention programs and/or beta-testing of the computerized intervention
- Physical limitations that will prevent adequate seeing/hearing of the intervention, or from using computer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Computer + Fluency
Will receive computerized intervention and will be required to periodically demonstrate mastery of information before proceeding to the next module in the computerized intervention.
|
|
Active Comparator: Computer Only
Will receive computerized intervention but will not be required to demonstrate mastery of information as part of the intervention.
|
|
Active Comparator: Treatment as Usual
Will receive publicly available pamphlets that contain same information as the computerized intervention.
Will not have access to computerized intervention and will not be required to demonstrate mastery of information as part of the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge Gain
Time Frame: Before the intervention (pre-test) and immediately after the intervention (post-test), an average of 10 minutes.
|
The primary outcome is based on performance in the randomized, controlled trial and is change from baseline on a knowledge test that is administered immediately before and after the intervention. At the time of the study, no validated scales to assess general information regarding overdose in a true/false manner were available. Therefore the study developed a scale for the purpose of measuring knowledge increase. The scale included 51 items, rated as "true", "false", or "I don't know" (to discourage random guessing from resulting in accurate responses accidentally). The answers to all items were included as part of the intervention content so it was possible for every answer to be learned. The scale was summed together as a single measure of number correct responses (range 0-51) with no subscales. Higher values indicated more correct responses. |
Before the intervention (pre-test) and immediately after the intervention (post-test), an average of 10 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent Participants Who Would Recommend the Intervention to a Family Member or Friend.
Time Frame: Immediately after the intervention (an average of 10 minutes).
|
Participant willingness (yes or no) to recommend the intervention to a family member or friend.
|
Immediately after the intervention (an average of 10 minutes).
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Opioid Overdose
- R21DA035327 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment as Usual
-
University of HoustonTexas Women's UniversityRecruitingTreatment as Usual | MISC InterventionUnited States
-
Amrit SinhaNational Health Service, United KingdomUnknownTreatment as Usual | Psychological InterventionUnited Kingdom
-
Nottinghamshire Healthcare NHS TrustUniversity of Nottingham; University of Southampton; University of Leicester; Institute...TerminatedTreatment as Usual | Employment, SupportedUnited Kingdom
-
New York UniversityPlanned Parenthood Federation of AmericaCompletedTreatment as Usual | New Behavioral ProtocolUnited States
-
Tampere UniversityCompletedTreatment as Usual | Narrative Exposure TherapyFinland
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Babes-Bolyai UniversityActive, not recruitingREThink Game | Treatment-as-usualRomania
-
Florida International UniversityCompletedBehavior Therapy + MI Intervention (Supporting Teens' Academic Needs Daily) | Treatment as Usual
-
Indiana UniversityUniversity of South Florida; National Institute on Minority Health and Health... and other collaboratorsCompletedModified DECIDE Intervention | Treatment as Usual Care GroupUnited States
-
Rhode Island HospitalRecruiting
Clinical Trials on Treatment as Usual
-
Universitätsklinikum Hamburg-EppendorfCompletedPerioperative AnxietyGermany
-
South London and Maudsley NHS Foundation TrustCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
McMaster UniversityNot yet recruiting
-
Gaia AGRecruitingType 2 DiabetesGermany
-
Centre for Addiction and Mental HealthCompleted
-
King's College LondonUnknown
-
University Hospital, AkershusUniversity of OsloActive, not recruiting
-
University of IndianapolisUniversity of Missouri, Kansas City; Missouri State UniversityCompletedHypertension | Diabete Type 2United States
-
Universitat Jaume IConsorcio Hospitalario Provincial de CastellónCompletedDepression | AnxietySpain
-
Kuopio University HospitalUniversity of Oslo; University of Eastern Finland; City of KuopioRecruiting